Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E Adjustments
Ratios

Contineum Therapeutics (CTNM) Accumulated Depreciation & Amortization (2023 - 2024)

Historic Accumulated Depreciation & Amortization for Contineum Therapeutics (CTNM) over the last 2 years, with Q4 2024 value amounting to $1.7 million.

  • Contineum Therapeutics' Accumulated Depreciation & Amortization rose 1624.92% to $1.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.7 million, marking a year-over-year increase of 1624.92%. This contributed to the annual value of $1.7 million for FY2024, which is 1624.92% up from last year.
  • Contineum Therapeutics' Accumulated Depreciation & Amortization amounted to $1.7 million in Q4 2024, which was up 1624.92% from $1.5 million recorded in Q4 2023.
  • In the past 5 years, Contineum Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $1.7 million in Q4 2024 and a low of $1.5 million during Q4 2023